[UPCKat] Has the UPC set too high burden to stop generic entry in Boehringer Ingelheim v Zentiva?

The IPKat is left puzzled in Lisbon...The UPCKat is back to report on the ability to demonstrate imminent infringement, and how the Lisbon Local Division of the UPC has endorsed the approach previously taken by the Dusseldorf Local Division on assessing the risk of imminent infringement.  Over to the team of Agathe Michel-de Cazotte, Hiske Roos and Christina Guazzi to break down